Page 1 of Clinical Trials for Drug Exemestane, 117 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin
Last Updated: July 13, 2010
Condition(s): Breast Neoplasms
2
Completed
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Last Updated: October 13, 2011
Condition(s): Breast Neoplasms
3
Completed
Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease
Last Updated: February 24, 2009
Condition(s): Breast Cancer
4
Active, not recruiting
24 Months of Exemestane or Letrozole to Treat Breast Cancer
Last Updated: December 8, 2009
Condition(s): Breast Cancer
5
Recruiting
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer
Last Updated: August 6, 2008
Condition(s): Breast Cancer
6
Recruiting
Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Last Updated: May 17, 2012
Condition(s): Lung Cancer; Non Small Cell Lung Cancer (NSCLC); Breast Cancer; ER+ Breast Cancer
7
Active, not recruiting
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)
Last Updated: May 22, 2012
Condition(s): Breast Cancer
8
Active, not recruiting
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
Last Updated: May 9, 2009
Condition(s): Breast Cancer
9
Active, not recruiting
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Last Updated: May 4, 2012
Condition(s): Breast Cancer
10
Active, not recruiting
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Last Updated: May 9, 2009
Condition(s): Breast Cancer
11
Recruiting
A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy
Last Updated: May 18, 2012
Condition(s): Metastatic ER+ Her2- Breast Cancer; Postmenopausal
12
Terminated
Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
Last Updated: March 21, 2009
Condition(s): Breast Cancer
13
Completed
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
Last Updated: March 1, 2010
Condition(s): Ovarian Cancer
14
Active, not recruiting
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
Last Updated: November 6, 2010
Condition(s): Breast Cancer
15
Recruiting
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Last Updated: February 7, 2012
Condition(s): Breast Cancer
16
Recruiting
Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Last Updated: June 16, 2009
Condition(s): Breast Cancer
17
Recruiting
Aromatase Inhibitor Clinical Trial
Last Updated: September 24, 2008
Condition(s): Breast Cancer
18
Recruiting
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Last Updated: May 14, 2012
Condition(s): Her2 Negative Breast Cancer Patients
19
Terminated
Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
Last Updated: January 24, 2012
Condition(s): Metastatic Breast Cancer
20
Recruiting
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
Last Updated: March 13, 2012
Condition(s): Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Exemestane

Page 1 of Clinical Trials for Drug Exemestane, 117 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About